A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Shanghai Pharma Biotherapeutics USA Inc.
Alliance for Clinical Trials in Oncology
Pfizer
Columbia University
Sarcoma Alliance for Research through Collaboration
Washington University School of Medicine
National Cancer Institute (NCI)
Northwestern University
OHSU Knight Cancer Institute
Institut Bergonié
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Vector Oncology
Memorial Sloan Kettering Cancer Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
H. Lee Moffitt Cancer Center and Research Institute